Actavia Life Sciences, Inc. (RASP)

OTCMKTS · Delayed Price · Currency is USD

0.0005

-0.0095 (-95.00%)

At close: Dec 26, 2025

Actavia Life Sciences Financials Overview

Financials in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Revenue & Profits

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Mar '24 Mar 31, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021	Sep '20 Sep 30, 2020	Sep '19 Sep 30, 2019
Operating Income	-0.35	-4.24	-0.38	-0.25	-0.56	-0.92
Net Income	-0.41	-4.44	-0.69	-0.88	-5.35	-0.94
Earnings Per Share	-0.00	-0.01	-0.01	-0.01	-0.08	-0.01
EPS Growth	-	-	-	-	-	-

Cash & Debt

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Mar '24 Mar 31, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021	Sep '20 Sep 30, 2020	Sep '19 Sep 30, 2019
Cash & Investments	0	0.07	0.04	0.01	0.01	0.05
Total Debt	0.3	0.21	0.22	0.68	0.52	0.26
Net Cash (Debt)	-0.3	-0.14	-0.18	-0.67	-0.51	-0.21
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-0.00	-0.00	-0.00	-0.01	-0.01	-0.00

Cash Flow & CapEx

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Mar '24 Mar 31, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021	Sep '20 Sep 30, 2020	Sep '19 Sep 30, 2019
Operating Cash Flow	-0.07	-0.01	-0.31	-0.29	-0.25	-0.09
Capital Expenditures	-	-	-	-	-	-
Free Cash Flow	-0.07	-0.01	-0.31	-0.29	-0.25	-0.09
Free Cash Flow Growth	-	-	-	-	-	-

Valuation

Selected indicators aren't available for this stock.